← All trials
NCT06139796
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2024
- Primary completion
- Jan 31, 2025
- Completion date
- Jun 30, 2026
- First posted
- Nov 18, 2023
- Last posted
- Nov 18, 2023
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- PENTA FoundationLead sponsor
- AMS-PHPT Research CollaborationCollaborator
- Baylor UniversityCollaborator
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- University of ZimbabweCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.